Stage II Breast Cancer Terminated Phase 2 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00194792Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTreatment